<DOC>
	<DOCNO>NCT01699659</DOCNO>
	<brief_summary>Hypothesis : The UAS Immunotherapy protocol efficacious least efficacious protocol describe Allergy literature .</brief_summary>
	<brief_title>The Efficacy &amp; Safety UAS Immunotherapy Protocol</brief_title>
	<detailed_description>Patients assess efficacy immunotherapy protocol complete Consented-IRB approve clinical , medication , quality life survey question compare current status therapy contrast 12 month inception therapy .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<criteria>Allergic rhinitis 18 65 year old choose undergo immunotherapy . No beta blocker use , pregnancy , systemic steroid , severe asthma/copd , severe collagen vascular disorder , neoplastic uncontrolled seizure activity , previous anaphylaxis , significant cardiovsacular disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Allergic Rhinitis</keyword>
	<keyword>Allergen Immunotherapy</keyword>
</DOC>